Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Effect of empagliflozin, a selective sodium-glucose cotransporter 2 inhibitor, on kidney and peripheral nerves in streptozotocin-induced diabetic rats
Participants were followed from the index date (date of the initial drug exposure) until the day of drug switching, death or 31 December 2019, whichever came first
Regulatory status : GLP-1 medications are prescription-only medicines licensed by the MHRA following rigorous evaluation of safety and efficacy data
the peptide to be purified is selected from GLP-2 (1-34), GLP-2 (1-33) as well as analogues and derivatives thereof, in particular but not limited to human glucagon-like peptide-2 (hGLP-2), GLP-2(1-30)
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
